Who’s Hired? Nichi-Iko Looks To Sandoz For Fresh Leadership
As Ethypharm And Krka Announce UK Appointments And Centrient Names Quality Head
Nichi-Iko has revealed its choice of new leadership, looking to Sandoz Japan for its next president and CEO. Meanwhile, Ethypharm and Krka have made fresh appointments in the UK and Centrient has named a new chief quality officer.
You may also be interested in...
What’s Next? Five Things To Look Out For In March
Prepare for all the biggest industry actions and events in March 2023 with Generics Bulletin’s monthly column.
Nichi-Iko Set To Delist In March As Tamura Steps Down As CEO
After nearly two difficult years for Nichi-Iko Pharmaceutical, the firm has announced at it will be acquired by a private equity fund and delisted from the Toyko Stock Exchange in 2023 and its CEO will step down from his post.
Nichi-Iko Aims To Regroup As It Enters Turnaround Process
Japan’s Nichi-Iko has formally entered a business turnaround alternative dispute resolution process that will see the company outline a business rehabilitation plan involving management restructuring and a fresh profit structure, following financial underperformance in the wake of recent quality issues.